<unk>  is a somatostatin analog that is FDA approved for the treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy.   Common adverse reactions include diarrhea, cholelithiasis, abdominal pain, nausea and injection site reactions.
Lanreotide
Octreotide
Metoclopramide 
Thiomersal
Protirelin
Rabeprazole
Hexetidine
Trenonacog alfa